Comparing 4% Articaine and 2% Lignocaine for Pain Relief in Childrens Lower Back Teeth, with assessment of Parent Satisfaction.

Comparison of 4% Articaine Buccal Infiltration and 2% Lignocaine Inferior Alveolar Nerve Block for Invasive Dental Procedures in Primary Mandibular Molars along with Assessment of Parental Satisfaction: An Equivalence Parallel Prospective Randomized Controlled Trial - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081335

Enrollment

134

Registered

2025-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 2% Lignocaine : primary mandibular molars undergoing extraction or pulp therapy will be administered inferior alveolar nerve block using 2% Lignocaine Intervention2: NIL: NIL Control I

Eligibility

Inclusion criteria

Inclusion criteria: patients medically healthy patients requiring invasive dental procedure patients showing understanding of pain scale co-operative patients primary molars requiring pulp therapy and extraction

Exclusion criteria

Exclusion criteria: medically compromised known allergy to local anesthesia uncooperative patients tooth other than primary molars children younger than 5 and older than 10 years of age

Design outcomes

Primary

Measure	Time frame
To improve patient co-operation and make dental procedure less traumatic by using articaine buccal infiltration instead of IANB with lignocaineTimepoint: Baseline	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Gunjan Yadav

Sardar Patel Post Graduate Institute of Dental and Medical Science

drgunjany@gmail.com9454109142

Outcome results